Strominnate Therapeutics
Lund, Sweden
Strominnate Therapeutics targets challenging tumors like Glioblastoma multiforme (GBM), the most prevalent and aggressive brain tumor affecting adults. Current treatment consists of surgery, radiation therapy, and chemotherapy, but unfortunately, there exists no effective cure for GBM yet. Furthermore, GBM does not respond to immunotherapy either. The company develops innovative solutions for tumors like GBM that do not respond to treatments so that they become sensitive to immunotherapies. Strominnate Therapeutics´s approach is based on their unique know-how and protected use of a new immune cell with anti-tumor and immunomodulatory properties, stroma microglia.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.strominnate.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Strominnate Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now